🇺🇸 FDA
Patent

US 9175062

Human soluble receptor for advanced glycation end products (sRAGE), methods of preparing human sRAGE, and treatment methods using sRAGE

granted A61KA61K38/177A61P

Quick answer

US patent 9175062 (Human soluble receptor for advanced glycation end products (sRAGE), methods of preparing human sRAGE, and treatment methods using sRAGE) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/177, A61P, A61P29/00, A61P9/00